News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Siyuan Cheng: Excited to share our latest research on prostate cancer
Photo of Siyuan Cheng from schoolofgradstudies.lsuhs.edu
Jul 29, 2024, 09:49

Siyuan Cheng: Excited to share our latest research on prostate cancer

Siyuan Cheng, Cancer biologist, Bioinformatician at LSU Health Shreveport, shared on X about a recent paper by Lin Li et al. titled “Systematic Multi-Omics Investigation of Androgen Receptor Driven Gene Expression and Epigenetics changes in Prostate Cancer” published in Biorxiv.

Authors: Lin Li, Kyung Hyun Cho, Xiuping Yu, Siyuan Cheng.

excited

“Excited to share our latest research on prostate cancer! We conducted a Systematic Multi-Omics Investigation to explore androgen receptor-driven gene expression and epigenetic changes.

Conclusions:

  1. AR regulates genes in critical pathways such as Wnt signaling.
  2. AR binds and modulates the chromatin status of distal enhancer regions, rather than proximal promoters.
  3. AR does not directly regulate genes in NE differentiation (lineage plasticity).

Excited

Excited to announce the launch of our new online app. This tool allows users to explore multi-omics dataset generated by this study.”

Excited

All our research data is now publicly available for download! We encourage researchers to access and utilize this data. Please find all links in App or manuscript.”

Excited

Source: Siyuan Cheng/X

cancer Epigenetic changes Kyung Hyun Cho Lin Li LSU Health Shreveport OncoDaily Oncology prostate cancer Research ResearchTools Siyuan Cheng Systematic Multi-Omics Investigation Xiuping Yu
Special Coverage
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer